Peripheral Intervention Drug-Eluting Devices Market
Peripheral Intervention Drug-Eluting Devices Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Peripheral Intervention Drug-Eluting Devices Market Size and Growth
The global Peripheral Intervention Drug-Eluting Devices market is projected to grow significantly due to increasing prevalence of peripheral artery disease. The market size is estimated to reach $3.5 billion by 2027, driven by technological advancements and rising demand for minimally invasive procedures. Key players include Medtronic, Abbott, and Boston Scientific.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Medtronic plc
◍ Boston Scientific Corporation
◍ Abbott Laboratories
◍ Cardinal Health
◍ B. Braun Melsungen AG
◍ Biosensors International Group Ltd.
◍ C.R. Bard, Inc.
◍ Abbott
◍ The Lubrizol Corporation
◍ Terumo Corporation
The competitive landscape of the Peripheral Intervention Drug-Eluting Devices Market includes key players such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott, The Lubrizol Corporation, and Terumo Corporation. These companies offer a range of innovative drug-eluting devices for peripheral interventions, contributing to market growth and expansion.
- Medtronic plc: $30.557 billion
- Boston Scientific Corporation: $10.735 billion
- Abbott Laboratories: $33.372 billion
Request Sample Report
Market Segmentation
By Application
◍ Plain Old Balloon Angioplasty (POBA)
◍ Percutaneous Transluminal Angioplasty (PTA)
By Product
◍ Drug-Eluting Balloons
◍ Drug-Eluting Stents
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients